- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01751750
Grape Polyphenol Kinetics in Humans
May 23, 2017 updated by: Janet Novotny
The objectives of this study are the following: 1) to confirm that the administration of grape juice, resveratrol, and grape seed polyphenol extract results in a similar plasma and urinary metabolic profile in aged humans compared to rats, 2) to confirm that a combined administration of grape juice, resveratrol, and grape seed polyphenol extract result in a similar plasma and urinary metabolic profile in adults with tendencies toward metabolic syndrome compared to non-obese healthy humans, and 3) to identify the anti-inflammatory effects of the combined administration of grape juice, resveratrol, and grape seed polyphenol extract.
Study Overview
Study Type
Interventional
Enrollment (Actual)
16
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Maryland
-
Beltsville, Maryland, United States, 20705
- USDA Beltsville Human Nutrition Research Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 59 years (Child, Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
-
Exclusion Criteria:
- Age <60 years at beginning of study
- Fasting glucose > 126 mg/dl
- Blood pressure > 160/100
- Fasting total blood cholesterol > 280 mg/dl
- Fasting triglycerides > 300 mg/dl
- Presence of kidney disease, liver disease, gout, hyperthyroidism, untreated or unstable hypothyroidism, certain cancers, gastrointestinal disease, pancreatic disease, other metabolic diseases, or malabsorption syndromes
- Presence of type 2 diabetes requiring the use of oral antidiabetic agents or insulin
- History of bariatric or certain other surgeries related to weight control
- Smokers or other tobacco users (during 6 months prior to the start of the study)
- Consumption of more than 3 servings of tea, wine, or grape juice per day
- Use of supplements containing grape extracts or products
- Use of antibiotics during the intervention or for 3 weeks prior to the intervention period
- History of eating disorders, dietary patterns, or supplement use which will interfere with the goal of the intervention
- Volunteers who have lost 10% of body weight within the last 4 months
- Volunteers who are unable or unwilling to give informed consent or communicate with study staff
- Volunteers who self-report of alcohol or substance abuse within the past 12 months and/or current acute treatment or rehabilitation program for these problems (long-term participation in Alcoholics Anonymous is not an exclusion)
- Other medical, psychiatric, or behavioral factors that in the judgment of the Principal Investigator may interfere with study participation or the ability to follow the intervention protocol
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Grape
|
16 oz. of Concord grape juice (8 oz.
consumed 2 times per day; total dose of approximately 1.2 g phenolic compounds per day), 250 mg resveratrol provided as a capsule (commercially available supplement; 125 mg consumed 2 times per day), and 1 g grape seed polyphenol extract provided as a capsule (commercially available supplement; 0.5 g consumed 2 times per day).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Plasma polyphenols
Time Frame: 6 hours
|
Blood will be analyzed for polyphenols and polyphenol metabolites.
|
6 hours
|
|
Urinary polyphenols
Time Frame: 6 hours
|
Urine will be analyzed for polyphenols and polyphenol metabolites.
|
6 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Janet Novotny, Ph.D., USDA Beltsville Human Nutrition Research Center
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2011
Primary Completion (Actual)
September 1, 2011
Study Completion (Actual)
September 1, 2011
Study Registration Dates
First Submitted
December 10, 2012
First Submitted That Met QC Criteria
December 13, 2012
First Posted (Estimate)
December 18, 2012
Study Record Updates
Last Update Posted (Actual)
May 25, 2017
Last Update Submitted That Met QC Criteria
May 23, 2017
Last Verified
May 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- HS38
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Volunteers
-
AstraZenecaCompletedHealthy Elderly Volunteers | Healthy Young VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
University Hospital, Clermont-FerrandUnite de Nutrition Humaine UMR 1019- INRAE; Unite MetaGenoPolis INRAE; France...CompletedHealthy Volunteers | Frail VolunteersFrance
-
Newcastle UniversityCompletedGI Glycaemic Index Healthy Volunteers | GL Glycaemic Load Healthy VolunteersUnited Kingdom
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
Galera Therapeutics, Inc.CelerionCompletedHealthy | Healthy VolunteersUnited States
-
Danone NutriciaCompletedHealthy Elderly | Healthy VolunteersChina
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
Clinical Trials on Grape
-
Western New England UniversityRecruiting
-
Nazarbayev UniversityNot yet recruitingBreast Cancer | Chemotherapy-induced Cardiotoxicity
-
University of California, DavisCompletedInflammation | Obesity | Cardiovascular Disease | Oxidative StressUnited States
-
Clinica Universidad de Navarra, Universidad de...CompletedHealthy | Glycaemic Response MeasurementsSpain
-
National University of SingaporeCalifornia Table Grape CommissionRecruitingAging | Macula; Degeneration | Advanced Glycation End ProductsSingapore
-
University of Lahore Hospital (ULH)Completed
-
University of Alabama at BirminghamCompleted
-
University of ConnecticutCalifornia Table Grape CommissionCompletedMetabolic Syndrome XUnited States
-
King's College LondonNaturex-DbsCompletedHealthy Men and WomenUnited Kingdom
-
National University of SingaporeNational University Hospital, Singapore; Ministry of Education, SingaporeActive, not recruitingAge-related Macular Degeneration | Eye HealthSingapore